Article(id=1330225265273320001, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.03.022, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1611417600000, receivedDateStr=2021-01-24, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080017630, onlineDateStr=2026-11-19, pubDate=1646841600000, pubDateStr=2022-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080017630, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080017630, creator=13701087609, updateTime=1795080017630, updator=13701087609, issue=Issue{id=1330225126483800273, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='3', pageStart='211', pageEnd='341', issueExtLink='null', onlineDate='null', pubDate='1646841600000', pubDateStr='2022-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079984541, creator='13701087609', updateTime=1795084691298, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244868573606556, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244868573606557, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=336, endPage=341, ext={EN=ArticleExt(id=1330225265495618116, articleId=1330225265273320001, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress in bimekizumab, the first dual inhibitor of interleukin-17A and interleukin-17F, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Interleukin (IL)-17, includes six subtypes such as IL-17A and IL-17F, plays an important role in the pathogenesis of a variety of immune-mediated diseases. The currently marketed IL-17A inhibitors have good effects on psoriasis, psoriatic arthritis and ankylosing spondylitis. Bimekizumab (UCB4940) is a noval humanized monoclonal immunoglobulin G1 antibody developed by Belgium's Utimes Company, which is designed to selectively bind to specific sites on IL-17A and IL-17F, and simultaneously inhibiting both IL-17A and IL17F, thereby producing a stronger anti-inflammatory effect than inhibiting IL-17A alone. The latest phase Ⅲ clinical study data show that bimekizumab is effective in treating psoriasis and is well tolerated. This article reviewed the pharmacology, pharmacokinetics, clinical efficacy evaluation and safety of bimekizumab.
, authors=Fang ZHANG, Jie LIU, Taohua SUN, Yan ZHAO
*, authorsList=Fang ZHANG, Jie LIU, Taohua SUN, Yan ZHAO, authorCompany=null, correspAuthors=Yan ZHAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225265738887749, articleId=1330225265273320001, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=首个白介素-17A和白介素-17F双重抑制剂bimekizumab的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
白介素-17(interleukin-17,IL-17)包括IL-17A、IL-17F等6种亚型,在多种免疫介导的疾病的发病机理中起重要作用。目前上市的IL-17A抑制剂对于银屑病(psoriasis),银屑病关节炎(psoriatic arthritis)和强直性脊柱炎(ankylosing spondylitis)均有良好疗效。bimekizumab(UCB4940)是由比利时优时比公司研发的一种新型人源化免疫球蛋白G1单克隆抗体,其能够与IL-17A和IL-17F上的特定位点选择性结合,同时对IL-17A和IL-17F效果产生抑制作用,从而产生比单独抑制IL-17A更为强大的抗炎效果。最新Ⅲ期临床研究数据显示bimekizumab治疗银屑病的效果确切,且耐受性好。该文对bimekizumab的药理学、药代动力学、临床疗效评价及安全性等情况作一概述。
, authors=张芳, 刘杰, 孙韬华, 赵艳
*, authorsList=张芳, 刘杰, 孙韬华, 赵艳, authorCompany=null, correspAuthors=赵艳, authorNote=
, correspAuthorsNote=
赵艳,主任药师,研究方向:医院药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=LpvIJWWLQzoZ/ukOMejACQ==, magXml=RMWKLCwd1yMPoUyDl4sFEQ==, pdfUrl=null, pdf=EWWtkheCDporCth3eLJFNg==, pdfFileSize=1776132, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=x4cDw0Zfd8IKlIlmxe5/Lw==, mapNumber=null, fund=null)}, authors=[Author(id=1330225266024100426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225266120569420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266024100426, language=EN, stringName=Fang ZHANG, firstName=Fang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225266187678285, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266024100426, language=CN, stringName=张芳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=青岛市市立医院药学部,山东 青岛 266011, bio={"content":"
张芳,硕士,副主任药师,研究方向:医院药学。
"}, bioImg=null, bioContent=
张芳,硕士,副主任药师,研究方向:医院药学。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225265944408646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, xref=null, ext=[AuthorCompanyExt(id=1330225265952797255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China), AuthorCompanyExt(id=1330225265961185864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=青岛市市立医院药学部,山东 青岛 266011)])]), Author(id=1330225266267370063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225266321896017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266267370063, language=EN, stringName=Jie LIU, firstName=Jie, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225266389004882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266267370063, language=CN, stringName=刘杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=青岛市市立医院药学部,山东 青岛 266011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225265944408646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, xref=null, ext=[AuthorCompanyExt(id=1330225265952797255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China), AuthorCompanyExt(id=1330225265961185864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=青岛市市立医院药学部,山东 青岛 266011)])]), Author(id=1330225266460308052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225266539999830, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266460308052, language=EN, stringName=Taohua SUN, firstName=Taohua, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225266607108695, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266460308052, language=CN, stringName=孙韬华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=青岛市市立医院药学部,山东 青岛 266011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225265944408646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, xref=null, ext=[AuthorCompanyExt(id=1330225265952797255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China), AuthorCompanyExt(id=1330225265961185864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=青岛市市立医院药学部,山东 青岛 266011)])]), Author(id=1330225266682606169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225266758103643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266682606169, language=EN, stringName=Yan ZHAO, firstName=Yan, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225266821018204, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, authorId=1330225266682606169, language=CN, stringName=赵艳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=青岛市市立医院药学部,山东 青岛 266011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225265944408646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, xref=null, ext=[AuthorCompanyExt(id=1330225265952797255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China), AuthorCompanyExt(id=1330225265961185864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=青岛市市立医院药学部,山东 青岛 266011)])])], keywords=[Keyword(id=1330225268469379679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=EN, orderNo=1, keyword=interleukin-17), Keyword(id=1330225268532294240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=EN, orderNo=2, keyword=inhibitor), Keyword(id=1330225268595208801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=EN, orderNo=3, keyword=psoriasis), Keyword(id=1330225268670706274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=EN, orderNo=4, keyword=ankylosing spondylitis), Keyword(id=1330225268754592355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=EN, orderNo=5, keyword=bimekizumab), Keyword(id=1330225268825895524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=CN, orderNo=1, keyword=白介素-17), Keyword(id=1330225268913975909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=CN, orderNo=2, keyword=抑制剂), Keyword(id=1330225269035610726, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=CN, orderNo=3, keyword=银屑病), Keyword(id=1330225269098525287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=CN, orderNo=4, keyword=强直性脊柱炎), Keyword(id=1330225269182411368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, language=CN, orderNo=5, keyword=bimekizumab)], refs=[Reference(id=1330225269434069610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Wright JF, Bennett F, Li B,
et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex[J]. J Immunol, 2008, 181(4): 2799-2805., articleTitle=null, refAbstract=null), Reference(id=1330225269501178475, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Przepiorka-Kosinska JM, Bartosinska J, Raczkiewicz D,
et al. Serum concentration of osteopontin and interleukin 17 in psoriatic patients[J]. Adv Clin Exp Med, 2020, 29(2): 203-208., articleTitle=null, refAbstract=null), Reference(id=1330225269564093036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=van Baarsen LG, Lebre MC, van der Coelen D,
et al. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?[J]. Arthritis Res Ther, 2014, 16(4): 426., articleTitle=null, refAbstract=null), Reference(id=1330225269631201901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Mei Y, Pan F, Gao J,
et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis[J]. Clin Rheumatol, 2011, 30(2): 269-273., articleTitle=null, refAbstract=null), Reference(id=1330225269715087984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Torres T, Romanelli M, Chiricozzi A. A revolutionary therapeutic approach for psoriasis: bispecific biological agents[J]. Expert Opin Investig Drugs, 2016, 25(7): 751-754., articleTitle=null, refAbstract=null), Reference(id=1330225269782196849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Kolls JK, Linden A. Interleukin-17 family members and inflammation[J]. Immunity, 2004, 21(4): 467-476., articleTitle=null, refAbstract=null), Reference(id=1330225269849305714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Wright JF, Guo Y, Quazi A,
et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4
+ T cells[J]. J Biol Chem, 2007, 282(18): 13447-13455., articleTitle=null, refAbstract=null), Reference(id=1330225269920608883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Ruiz de Morales JMG, Puig L, Dauden E,
et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies[J]. Autoimmun Rev, 2020, 19(1): 102429., articleTitle=null, refAbstract=null), Reference(id=1330225269979329140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Adams R, Maroof A, Baker T,
et al. Bimekizumab, a novel humanized IgG1 antibody that neutralizes both IL-17A and IL-17F[J]. Front Immunol, 2020, 11: 1894., articleTitle=null, refAbstract=null), Reference(id=1330225270046438005, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Glatt S, Baeten D, Baker T,
et al. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation[J]. Ann Rheum Dis, 2018, 77(4): 523-532., articleTitle=null, refAbstract=null), Reference(id=1330225270117741175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Langley RG, Elewski BE, Lebwohl M,
et al. Secukinumab in plaque psoriasis-results of two phase 3 trials[J]. N Engl J Med, 2014, 371(4): 326-338., articleTitle=null, refAbstract=null), Reference(id=1330225270189044344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Mease PJ, van der Heijde D, Ritchlin CT,
et al. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase Ⅲ trial SPIRIT-P1[J]. Ann Rheum Dis, 2017, 76(1): 79-87., articleTitle=null, refAbstract=null), Reference(id=1330225270260347513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Baeten D, Sieper J, Braun J,
et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis[J]. N Engl J Med, 2015, 373(26): 2534-2548., articleTitle=null, refAbstract=null), Reference(id=1330225270348427898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Kolbinger F, Loesche C, Valentin MA,
et al. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis[J]. J Allergy Clin Immunol, 2017, 139(3): 923-932., articleTitle=null, refAbstract=null), Reference(id=1330225270423925371, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Babaie F, Mohammadi H, Hemmatzadeh M,
et al. Evaluation of
ERAP1 gene single nucleotide polymorphisms in immunomodulation of pro-inflammatory and anti-inflammatory cytokines profile in ankylosing spondylitis[J]. Immunol Lett, 2020, 217: 31-38., articleTitle=null, refAbstract=null), Reference(id=1330225270503617148, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Glatt S, Helmer E, Haier B,
et al. First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis[J]. Br J Clin Pharmacol, 2017, 83(5): 991-1001., articleTitle=null, refAbstract=null), Reference(id=1330225270566531709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Papp KA, Merola JF, Gottlieb AB,
et al. Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial[J]. J Am Acad Dermatol, 2018, 79(2): 277-286., articleTitle=null, refAbstract=null), Reference(id=1330225270637834878, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Blauvelt A, Papp KA, Merola JF,
et al. Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study[J]. J Am Acad Dermatol, 2020, 83(5): 1367-1374, articleTitle=null, refAbstract=null), Reference(id=1330225270700749439, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=UCB S. A. Belgium. First presentations of bimekizumab phase 3 data demonstrate superior skin clearance over placebo and stelara[
®] at week 16 in adults with moderate-to-severe plaque psoriasis[EB/OL]. (2020-06-12) [2020-10-15]. https://www.ucb.com., articleTitle=null, refAbstract=null), Reference(id=1330225270780441216, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Ritchlin CT, Kavanaugh A, Merola JF,
et al. Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial[J]. Lancet, 2020, 395(10222): 427-440., articleTitle=null, refAbstract=null), Reference(id=1330225270847550081, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=van der Heijde D, Gensler LS, Deodhar A,
et al. Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase Ⅱb, randomised, double-blind, placebo-controlled, dose-ranging study[J]. Ann Rheum Dis, 2020, 79(5): 595-604., articleTitle=null, refAbstract=null), Reference(id=1330225270914658946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Whibley N, Tritto E, Traggiai E,
et al. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis[J]. J Leukoc Biol, 2016, 99(6): 1153-1164., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330225269320823401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, awardId=2018-WJZD010, language=CN, fundingSource=青岛市2018年度医药科研指导计划(2018-WJZD010), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330225265944408646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, xref=null, ext=[AuthorCompanyExt(id=1330225265952797255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Qingdao Municipal Hospital, Qingdao 266011, Shandong Province, China), AuthorCompanyExt(id=1330225265961185864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225265273320001, companyId=1330225265944408646, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=青岛市市立医院药学部,山东 青岛 266011)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.03.022, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.03.022, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.03.022, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.03.022, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1646841600000, fullTextJson=null, articleText=null, reference=null)